Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

TTOO

T2 Biosystems Inc

Dec 13 • 04:00PM ET

0.3650

Dollar change -0.0849
Percentage change -18.87	%

Healthcare • Diagnostics & Research • USA • NASD

Peers: ILMN BIO EXAS CDNA GH CRSP FLGT MYGN AXNX

| Held by: VTI VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-6.41	Insider Own	55.60%	Shs Outstand	18.76M	Perf Week	-28.43%
Market Cap	6.23M	Forward P/E	-	EPS next Y	-	Insider Trans	-0.00%	Shs Float	9.34M	Perf Month	-33.39%
Income	-42.95M	PEG	-	EPS next Q	-0.17	Inst Own	10.23%	Short Float	9.37%	Perf Quarter	-84.20%
Sales	7.68M	P/S	0.81	EPS this Y	-	Inst Trans	-11.61%	Short Ratio	1.23	Perf Half Y	-92.86%
Book/sh	-0.62	P/B	-	EPS next Y	-	ROA	-140.00%	Short Interest	0.88M	Perf Year	-90.03%
Cash/sh	0.12	P/C	3.00	EPS next 5Y	-	ROE	-	52W Range	0.42 - 8.38	Perf YTD	-94.18%
Dividend Est.	-	P/FCF	-	EPS past 5Y	68.62%	ROI	-	52W High	-95.64%	Beta	0.36
Dividend TTM	-	Quick Ratio	0.24	Sales past 5Y	12.68%	Gross Margin	-77.73%	52W Low	-12.18%	ATR (14)	0.07
Dividend Ex-Date	-	Current Ratio	0.40	EPS Y/Y TTM	97.74%	Oper. Margin	-542.59%	RSI (14)	23.82	Volatility	13.44% 13.20%
Employees	113	Debt/Eq	-	Sales Y/Y TTM	-30.19%	Profit Margin	-559.52%	Recom	3.00	Target Price	5.00
Option/Short	No / Yes	LT Debt/Eq	-	EPS Q/Q	83.59%	Payout	-	Rel Volume	2.90	Prev Close	0.45
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	34.85%	Earnings	Nov 14 AMC	Avg Volume	708.89K	Price	0.37
SMA20	-26.48%	SMA50	-58.35%	SMA200	-88.51%	Trades		Volume	2,052,864	Change	-18.87%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-27-21	Downgrade	Alliance Global Partners	Buy → Neutral	$2.60 → $2.40
Oct-08-20	Initiated	BTIG Research	Buy	$2.50
Nov-26-19	Downgrade	Janney	Buy → Neutral
Aug-01-19	Downgrade	Alliance Global Partners	Buy → Neutral
Jul-31-19	Downgrade	Janney	Buy → Neutral
Jul-31-19	Downgrade	H.C. Wainwright	Buy → Neutral
May-16-19	Initiated	Alliance Global Partners	Buy	$5
Mar-08-19	Reiterated	H.C. Wainwright	Buy	$14 → $11
Jun-01-18	Upgrade	Leerink Partners	Mkt Perform → Outperform
May-30-18	Reiterated	H.C. Wainwright	Buy	$8.50 → $14
May-29-18	Reiterated	WBB Securities	Strong Buy	$12 → $20
Mar-29-18	Reiterated	H.C. Wainwright	Buy	$8 → $8.50
Jan-29-18	Initiated	Goldman	Neutral	$5.20
Oct-18-17	Initiated	H.C. Wainwright	Buy	$8
Mar-15-17	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Nov-10-16	Resumed	Leerink Partners	Mkt Perform	$5
Nov-02-16	Reiterated	Cantor Fitzgerald	Buy	$10 → $9
Jul-20-16	Upgrade	WBB Securities	Buy → Strong Buy	$11 → $12
Jun-22-16	Upgrade	WBB Securities	Speculative Buy → Buy	$11
Apr-12-16	Reiterated	Canaccord Genuity	Buy	$13 → $12

Show Previous Ratings

Dec-09-24 09:00AM	T2 Biosystems Announces Plans to License its Proprietary Technology to Expand its Leadership in Direct-From-Whole-Blood Detection of Sepsis-Causing Pathogens (GlobeNewswire)
Nov-15-24 02:15AM	T2 Biosystems Inc (TTOO) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic ... (GuruFocus.com)
Nov-14-24 04:25PM	T2 Biosystems: Q3 Earnings Snapshot (Associated Press Finance) -5.11%
04:05PM	T2 Biosystems Announces Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-05-24 08:00AM	T2 Biosystems to Report Third Quarter 2024 Financial Results and Business Updates on November 14, 2024 (GlobeNewswire)
07:19AM	Loading…
Oct-11-24 07:19AM	Q3 2024 T2 Biosystems Inc Earnings Call (Thomson Reuters StreetEvents)
03:01AM	T2 Biosystems Inc (TTOO) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic ... (GuruFocus.com)
Oct-08-24 04:05PM	T2 Biosystems to Host Business Update Call on October 10, 2024 (GlobeNewswire)
09:00AM	T2 Biosystems, Inc. and Prxcision, Inc. Announce Co-Marketing Collaboration for Rapid Direct-From-Blood Diagnostics and AI-Powered Decision Support Platform (GlobeNewswire)
Oct-07-24 09:05AM	T2 Biosystems Announces Exclusive U.S. Agreement with Cardinal Health to Sell its FDA-Cleared Direct-From-Blood Diagnostics for Rapid Detection of Sepsis-Causing Pathogens (GlobeNewswire) -10.44%
09:00AM	T2 Biosystems Announces Preliminary Third Quarter 2024 Financial Results (GlobeNewswire)
Sep-23-24 09:00AM	T2 Biosystems Highlights New Article Published in The Lancet: Changing the Culture of Blood Culture (GlobeNewswire) -5.94%
Sep-20-24 09:00AM	T2 Biosystems Achieves Successful Defense of Patent for Direct-From-Whole Blood Pathogen Detection Method in the European Union (GlobeNewswire)
Sep-16-24 09:00AM	T2 Biosystems Receives FDA Clearance to Market the T2Candida Panel for Pediatric Patients (GlobeNewswire) -8.70%
Sep-09-24 09:00AM	T2 Biosystems Provides Updates on its New Product Development Pipeline Progress (GlobeNewswire) -9.15%
04:05PM	Loading…
Aug-27-24 04:05PM	T2 Biosystems to Participate in the H.C. Wainwright 26th Annual Global Investment Conference (GlobeNewswire) +5.98% -9.68%
Aug-01-24 04:05PM	T2 Biosystems to Attend Upcoming Investor Conferences (GlobeNewswire)
Jul-30-24 12:22PM	Q2 2024 T2 Biosystems Inc Earnings Call (Thomson Reuters StreetEvents)
Jul-29-24 04:49PM	T2 Biosystems: Q2 Earnings Snapshot (Associated Press Finance) -6.88%
04:05PM	T2 Biosystems Announces Second Quarter 2024 Financial Results (GlobeNewswire)
04:02PM	T2 Biosystems Announces Commercial Expansion Through Malaysia and Indonesia Distributor (GlobeNewswire)
Jul-22-24 04:05PM	T2 Biosystems to Report Second Quarter 2024 Financial Results and Business Updates on July 29, 2024 (GlobeNewswire)
Jul-08-24 08:15AM	Avacta Announces the Appointment of Darlene Deptula-Hicks as Non-Executive Director of the Board of Directors (GlobeNewswire)
Jun-25-24 09:00AM	T2 Biosystems Announces Commercial Expansion Through Hong Kong and Macau Distributor (GlobeNewswire) -9.16%
May-22-24 09:00AM	T2 Biosystems Regains Compliance with Nasdaq Continued Listing Requirements (GlobeNewswire)
May-17-24 04:05PM	T2 Biosystems Announces Closing of $8 Million Private Placement Priced At-The-Market Under Nasdaq Rules (GlobeNewswire) +7.45%
May-15-24 03:52PM	Sector Update: Health Care Stocks Advance Late Wednesday Afternoon (MT Newswires) +43.51%
01:45PM	T2 Biosystems Shares Rise After CRG Servicing Ups Stake (MT Newswires)
01:10PM	Top Midday Gainers (MT Newswires)
07:00AM	T2 Biosystems Announces $8 Million Private Placement Priced At-The-Market Under Nasdaq Rules (GlobeNewswire)
05:00PM	Loading…
May-14-24 05:00PM	T2 Biosystems Announces CRG's Conversion from Preferred Stock to Common Stock (GlobeNewswire) -5.24%
May-07-24 09:00AM	T2 Biosystems Announces Letter of Intent to Enter Strategic Partnership for Lyme Disease (GlobeNewswire) -10.74%
08:48AM	T2 Biosystems, Inc. (NASDAQ:TTOO) Q1 2024 Earnings Call Transcript (Insider Monkey)
06:11AM	Q1 2024 T2 Biosystems Inc Earnings Call (Thomson Reuters StreetEvents)
03:09AM	T2 Biosystems Inc (TTOO) Q1 2024 Earnings Call Transcript Highlights: Revenue Growth Amidst ... (GuruFocus.com)
May-06-24 08:58PM	TTOO Stock Earnings: T2 Biosystems Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
04:45PM	T2 Biosystems: Q1 Earnings Snapshot (Associated Press Finance)
04:34PM	T2 Biosystems Announces First Quarter 2024 Financial Results (GlobeNewswire)
04:34PM	T2 Biosystems Announces Commercial Expansion Through Middle East Distributor (GlobeNewswire)
04:29PM	T2 Biosystems Announces the Conversion of an Additional $15 Million of CRG Term Loan into Equity (GlobeNewswire)
Apr-24-24 09:00AM	T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024 (GlobeNewswire)
Apr-23-24 07:39AM	Top Premarket Decliners (MT Newswires) -13.92%
Apr-11-24 04:05PM	T2 Biosystems Shareholders Vote for CRG Debt Conversion into Equity (GlobeNewswire)
Mar-28-24 09:00AM	T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc. (GlobeNewswire)
Mar-20-24 07:30AM	T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business Updates (GlobeNewswire) -10.89%
Mar-19-24 09:00AM	T2 Biosystems to Host Investor Call on March 20, 2024 to Unveil its T2Lyme Launch Plans and Provide Additional Business Updates (GlobeNewswire) -11.20%
Mar-18-24 09:00AM	T2 Biosystems Announces New Publication Highlighting the Clinical Benefits and Performance of the T2Resistance Panel (GlobeNewswire) -5.98%
Mar-12-24 03:16PM	TTOO Stock: T2 Biosystems Has Until May 20 to Regain Nasdaq Compliance (InvestorPlace)
09:00AM	T2 Biosystems Receives Extension to Comply with Nasdaq Listing Requirement (GlobeNewswire)
Feb-16-24 09:29AM	T2 Biosystems, Inc. (NASDAQ:TTOO) Q4 2023 Earnings Call Transcript (Insider Monkey) -14.71%
06:08AM	Q4 2023 T2 Biosystems Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-15-24 04:06PM	T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
04:04PM	T2 Biosystems Announces Agreement with CRG for the Conversion of $15 Million of CRG Term Loan into Equity (GlobeNewswire)
04:02PM	T2 Biosystems Announces Commercial Expansion Through Distributors in Europe and Asia (GlobeNewswire)
Feb-12-24 12:12PM	T2 Biosystems Receives 510(K) Clearance for Its Bacteria Panel (InvestorPlace) +32.72%
09:00AM	T2 Biosystems Receives FDA 510(k) Clearance for the Expanded T2Bacteria Panel (GlobeNewswire)
Feb-07-24 04:05PM	T2 Biosystems to Report Fourth Quarter and Full Year 2023 Financial Results and Business Updates on February 15, 2024 (GlobeNewswire)
09:00AM	U.S. Department of Health and Human Services and Steven and Alexandra Cohen Foundation Name T2 Biosystems a Phase 2 Winner in the LymeX Diagnostics Prize (GlobeNewswire)
Jan-18-24 09:00AM	T2 Biosystems Announces Participation in NIH-funded Antibacterial Resistance Leadership Group (ARLG) Pilot Study for Pneumonia Patients (GlobeNewswire)
Jan-03-24 09:00AM	T2 Biosystems Announces FDA 510(k) Submission to Expand Use of the FDA-Cleared T2Candida Panel to Include Pediatric Testing (GlobeNewswire) +13.31%
Nov-15-23 07:24AM	T2 Biosystems: Q3 Earnings Snapshot (Associated Press Finance)
Nov-03-23 09:00AM	T2 Biosystems to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (GlobeNewswire) -7.99%
Nov-01-23 01:02PM	TTOO Stock Alert: T2 Biosystems Regains Nasdaq Compliance (InvestorPlace)
09:00AM	T2 Biosystems Regains Compliance with Nasdaq Listing Requirements (GlobeNewswire)
Oct-24-23 04:05PM	T2 Biosystems Highlights New Clinical Data Presented at IDWeek 2023 Conference (GlobeNewswire) +9.50% +6.05%
Oct-23-23 09:00AM	T2 Biosystems Announces Amendment and Extension of CRG Term Loan Agreement (GlobeNewswire)
Oct-16-23 08:47AM	T2 Biosystems, Inc. (NASDAQ:TTOO) Q3 2023 Earnings Call Transcript (Insider Monkey) -11.59%
Oct-13-23 12:29PM	Why Is T2 Biosystems (TTOO) Stock Down 48% Today? (InvestorPlace) -52.87%
12:09PM	Why Shares of T2 Biosystems Are Falling Friday (Motley Fool)
Oct-12-23 04:05PM	T2 Biosystems Announces Preliminary Third Quarter 2023 Financial Results and Business Updates (GlobeNewswire) -43.87%
04:02PM	T2 Biosystems Announces FDA 510(k) Submission to Expand the Pathogen Detection on its FDA-Cleared T2Bacteria Panel to Include Detection of Acinetobacter baumannii (GlobeNewswire)
12:09PM	TTOO Stock Alert: T2 Biosystems Announces Reverse Stock Split (InvestorPlace)
09:00AM	T2 Biosystems Announces Reverse Stock Split Effective Today (GlobeNewswire)
Oct-06-23 04:07PM	T2 Biosystems Reports Granting of Inducement Award (GlobeNewswire) +35.67% +6.51%
10:04AM	Dear TTOO Stock Fans, Mark Your Calendars for Oct. 12 (InvestorPlace)
07:30AM	T2 Biosystems (TTOO) vs. IDEXX Laboratories (IDXX): Which Medical Stock Is Poised for More October Gains? (Entrepreneur: Stocks)
Oct-05-23 04:05PM	T2 Biosystems to Report Preliminary Third Quarter 2023 Financial Results and Business Updates on October 12, 2023 (GlobeNewswire)
Sep-19-23 09:00AM	T2 Biosystems Receives FDA 510(k) Clearance for the T2Biothreat Panel (GlobeNewswire) -26.13%
Sep-15-23 04:05PM	T2 Biosystems Reports Granting of Inducement Award (GlobeNewswire) +6.08% +65.55%
Sep-11-23 03:52PM	The Fun Is Over for TTOO Stock At Least for Now (InvestorPlace) -14.11%
Sep-07-23 04:05PM	T2 Biosystems to Participate in the Gilmartin Group Emerging Growth Company Showcase (GlobeNewswire) +13.92% -11.49%
Aug-28-23 08:30AM	T2 Biosystems Praises CDCs Actions Aimed at Optimizing U.S. Hospital Sepsis Programs (GlobeNewswire) -8.84%
Aug-24-23 12:35PM	Is T2 Biosystems a Hidden Gem or a Value Trap? An In-Depth Analysis (GuruFocus.com) -26.35%
Aug-15-23 10:20AM	Sidoti Events, LLCs Virtual August Micro-Cap Conference (ACCESSWIRE) +51.56%
Aug-14-23 12:38PM	4 Meme Stocks to Sell Before They Die (InvestorPlace) +15.42%
Aug-10-23 11:11AM	T2 Biosystems (TTOO) Stock Is Becoming the Next Mullen (InvestorPlace)
Aug-09-23 06:10PM	3 Meme Stocks to Sell in August Before They Crash and Burn (InvestorPlace) +10.48%
08:30AM	T2 Biosystems Regains Compliance with Nasdaqs Market Value of Listed Securities Requirement (GlobeNewswire)
08:00AM	Is TTOO Stock Really Worth $5? Or Just 5 Cents? (InvestorPlace)
06:32AM	T2 Biosystems, Inc. (NASDAQ:TTOO) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-08-23 07:42AM	Q2 2023 T2 Biosystems Inc Earnings Call (Thomson Reuters StreetEvents) +26.69%
Aug-07-23 04:22PM	T2 Biosystems: Q2 Earnings Snapshot (AP Finance)
04:05PM	T2 Biosystems Announces Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-31-23 09:29PM	GSA Capital Partners LLP Acquires Stake in T2 Biosystems Inc (GuruFocus.com) +27.16% +6.78%
08:30AM	T2 Biosystems Receives Extension to Comply with Nasdaq Listing Requirements (GlobeNewswire)
Jul-28-23 08:30AM	T2 Biosystems to Attend Upcoming Investor Conferences (GlobeNewswire)
Jul-24-23 04:05PM	T2 Biosystems to Report Second Quarter 2023 Financial Results on August 7, 2023 (GlobeNewswire) -6.36% +18.77%
Jul-21-23 04:05PM	T2 Biosystems Reports Granting of Inducement Award (GlobeNewswire)
Jul-20-23 08:30AM	T2 Biosystems Receives FDA Breakthrough Device Designation for Candida Auris Diagnostic Test (GlobeNewswire)
Jul-12-23 03:59PM	7 Doomed Stocks Destined for Disaster (InvestorPlace) -15.74%

T2 Biosystems, Inc. is a vitro diagnostics company, which engages in the development of detection of sepsis-causing pathogens. It offers T2Dx instrument, T2Bacteria, T2Candida, T2Biothreat panels, and T2MR technology. The company was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee, and Ralph Weissleder on April 27, 2006 and is headquartered in Lexington, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Elsbree David B	Director	Sep 13 '24	Sale	2.42	55	133	23	Sep 17 05:00 PM
Elsbree David B	Director	Sep 13 '24	Proposed Sale	2.41	55	132		Sep 13 10:31 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

TTOO

T2 Biosystems Inc

Upgrade your FINVIZ experience